Agency Forms Undergoing Paperwork Reduction Act Review, 41267-41268 [2017-18407]
Download as PDF
41267
Federal Register / Vol. 82, No. 167 / Wednesday, August 30, 2017 / Notices
questionnaires and provide samples for
laboratory testing.
Researchers will follow all studyparticipating mothers’ newborns every
other week from birth to 6 months of
age. At all visits, infants will receive
national recommended clinical care (at
birth and follow-up visits at 1, 2, and 6
months), provide samples for laboratory
testing, and mothers will complete
study-specific questionnaires about
infant ZIKV symptoms and
developmental milestones. During
follow-up, infants will also have cranial
performed to exam developmental
delays.
Researchers will use the study results
use to guide recommendations made by
both INS and CDC to prevent ZIKV
infection; to improve counseling of
patients about risks to themselves, their
pregnancies, their partners, and their
infants; and to help agencies prepare to
provide services to affected children
and families. Participation in this study
is voluntary and there are no costs to
participants other than their time.
ultrasounds, their head circumference
measured, and hearing and vision tests.
For mothers and their infants,
researchers will abstract relevant
clinical care information from medical
records.
The revised information collection
package includes the following changes.
During the data collection period,
researchers will follow a subset of 300
infants until 2-years of age. These
infants will have answer questionnaires
at 6, 12, 18, and 24 months, as well as
have other clinical assessments
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
Respondents
Form name
Pregnant women ...................
Pregnant women eligibility questionnaire ....
Pregnant women enrollment questionnaire
Adult symptoms questionnaire .....................
Pregnant women follow-up questionnaire ....
Infant symptoms questionnaire ....................
Ages and Stages Questionnaire: 2, 4, 6
Month.
Ages and Stages Questionnaire: 12, 18, 24
Month.
Center for Epidemiologic Studies Depression—10.
Male partner eligibility questionnaire ...........
Male enrollment questionnaire .....................
Adult symptoms questionnaire .....................
3,125
2,500
2,500
2,500
2,250
2,250
300
300
1
1
15
8
14
2
3
3
5/60
35/60
10/60
15/60
10/60
15/60
15/60
5/60
260
1,458
6,250
5,000
5,250
1,125
225
75
2,500
625
625
1
1
7
5/60
25/60
10/60
208
260
729
.......................................................................
........................
........................
........................
20,840
Male partners ........................
Total ...............................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–18405 Filed 8–29–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–17–0004]
mstockstill on DSK30JT082PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
VerDate Sep<11>2014
17:40 Aug 29, 2017
Jkt 241001
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
National Disease Surveillance
Program II. Disease Summaries (OMB
Control Number 0920–0004, Expires
10/31/2017)—Revision—National
Center for Immunization and
Respiratory Diseases, Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC requests a three-year approval for
the proposed revision of the ‘‘National
Disease Surveillance Program II. Disease
Summaries’’ information collection
project.
As with the previous approval, these
data are essential for measuring trends
in diseases, evaluating the effectiveness
of current preventive strategies, and
determining the need to modify current
preventive measures.
E:\FR\FM\30AUN1.SGM
30AUN1
41268
Federal Register / Vol. 82, No. 167 / Wednesday, August 30, 2017 / Notices
Diseases included in this surveillance
program are Influenza Virus,
Caliciviruses, Respiratory and Enteric
Viruses, Foodborne Outbreaks,
Waterborne Outbreaks and
Enteroviruses.
Proposed revisions include form
consolidation, minor revised language
and rewording to improve clarity and
readability of the data collection forms
and the discontinuation of multiple
previously approved influenza
collection instruments, and the National
Respiratory & Enteric Virus Surveillance
System (NREVSS) Laboratory
Assessment (CDC 55.83). CDC also
requests the use of a new form, Suspect
Respiratory Virus Patient Form, to assist
health departments and clinical sites
when they submit specimens to the CDC
lab for viral pathogen identification. The
data will enable rapid detection and
characterization of outbreaks of known
pathogens, as well as potential newly
emerging viral pathogens.
The frequency of response for each
form will depend on the disease and
surveillance need. This represents a
7,116 burden hour reduction since last
approval. This reduction in burden
hours is attributed primarily to the
discontinuation of previously approved
forms and formatting changes to existing
forms. The total time burden estimate
for all collection instruments in this
revision request is 24,805.
There are no costs to the respondents
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Epidemiologist ............
NORS Foodborne Disease Transmission_Person to Person Disease
Transmission_Animal Contact_Environmental Contamination_Unknown Transmission Mode_52.13.
WHO COLLABORATING CENTER FOR INFLUENZA Influenza
Virus Surveillance.
U.S. WHO Collaborating Laboratories Influenza Testing Methods
Assessment.
US Outpatient Influenza-like Illness Surveillance Network (ILINet)
Weekly_CDC 55.20.
US Outpatient Influenza-like Illness Surveillance Network (ILINet)
Workfolder 55.20E.
Influenza-Associated Pediatric Mortality Case Report Form ..............
Human Infection with Novel Influenza A Virus Case Report Form ....
Human Infection with Novel Influenza A Virus Severe Outcomes .....
Novel Influenza A Virus Case Screening Form ..................................
Antiviral Resistant Influenza Infection Case Report Form ..................
National Respiratory & Enteric Virus Surveillance System
(NREVSS) (55.83A, B, D) (electronic).
National Enterovirus Surveillance Report: (CDC 55.9) (electronic) ....
National Adenovirus Type Reporting System (NATRS) .....................
Middle East Respiratory Syndrome (MERS) Patient Under Investigation (PUI) Short Form.
Viral Gastroenteritis Outbreak Submission Form ................................
NORS Waterborne Disease Transmission Form_52.12 .....................
Influenza Virus (Electronic, Year Round), PHLIP_HL7 messaging
Data Elements.
Influenza virus (electronic, year round) (PHIN–MS) ...........................
Suspect Respiratory Virus Patient Form .............................................
Epidemiologist ............
Epidemiologist ............
Epidemiologist ............
Epidemiologist ............
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
............
............
............
............
............
............
Epidemiologist ............
Epidemiologist ............
Epidemiologist ............
Epidemiologist ............
Epidemiologist ............
Epidemiologist ............
Epidemiologist ............
Epidemiologist ............
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–18407 Filed 8–29–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier CMS–10239]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
BILLING CODE 4163–18–P
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
mstockstill on DSK30JT082PROD with NOTICES
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
SUMMARY:
VerDate Sep<11>2014
17:40 Aug 29, 2017
Jkt 241001
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Avg. burden
per response
(in hours)
54
37
20/60
53
52
10/60
113
1
10/60
1,800
52
10/60
1800
1
5/60
57
57
57
57
57
550
2
2
1
1
3
52
30/60
30/60
90/60
15/60
30/60
15/60
20
13
57
12
4
3
15/60
15/60
25/60
20
59
57
5
1
52
5/60
20/60
5/60
3
10
52
5
5/60
30/60
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected; and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
E:\FR\FM\30AUN1.SGM
30AUN1
Agencies
[Federal Register Volume 82, Number 167 (Wednesday, August 30, 2017)]
[Notices]
[Pages 41267-41268]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18407]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-17-0004]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
National Disease Surveillance Program II. Disease Summaries (OMB
Control Number 0920-0004, Expires 10/31/2017)--Revision--National
Center for Immunization and Respiratory Diseases, Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
CDC requests a three-year approval for the proposed revision of the
``National Disease Surveillance Program II. Disease Summaries''
information collection project.
As with the previous approval, these data are essential for
measuring trends in diseases, evaluating the effectiveness of current
preventive strategies, and determining the need to modify current
preventive measures.
[[Page 41268]]
Diseases included in this surveillance program are Influenza Virus,
Caliciviruses, Respiratory and Enteric Viruses, Foodborne Outbreaks,
Waterborne Outbreaks and Enteroviruses.
Proposed revisions include form consolidation, minor revised
language and rewording to improve clarity and readability of the data
collection forms and the discontinuation of multiple previously
approved influenza collection instruments, and the National Respiratory
& Enteric Virus Surveillance System (NREVSS) Laboratory Assessment (CDC
55.83). CDC also requests the use of a new form, Suspect Respiratory
Virus Patient Form, to assist health departments and clinical sites
when they submit specimens to the CDC lab for viral pathogen
identification. The data will enable rapid detection and
characterization of outbreaks of known pathogens, as well as potential
newly emerging viral pathogens.
The frequency of response for each form will depend on the disease
and surveillance need. This represents a 7,116 burden hour reduction
since last approval. This reduction in burden hours is attributed
primarily to the discontinuation of previously approved forms and
formatting changes to existing forms. The total time burden estimate
for all collection instruments in this revision request is 24,805.
There are no costs to the respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Epidemiologist....................... NORS Foodborne Disease 54 37 20/60
Transmission_Person to
Person Disease
Transmission_Animal
Contact_Environmental
Contamination_Unknown
Transmission Mode_52.13.
Epidemiologist....................... WHO COLLABORATING CENTER 53 52 10/60
FOR INFLUENZA Influenza
Virus Surveillance.
Epidemiologist....................... U.S. WHO Collaborating 113 1 10/60
Laboratories Influenza
Testing Methods
Assessment.
Epidemiologist....................... US Outpatient Influenza- 1,800 52 10/60
like Illness
Surveillance Network
(ILINet) Weekly_CDC
55.20.
Epidemiologist....................... US Outpatient Influenza- 1800 1 5/60
like Illness
Surveillance Network
(ILINet) Workfolder
55.20E.
Epidemiologist....................... Influenza-Associated 57 2 30/60
Pediatric Mortality Case
Report Form.
Epidemiologist....................... Human Infection with 57 2 30/60
Novel Influenza A Virus
Case Report Form.
Epidemiologist....................... Human Infection with 57 1 90/60
Novel Influenza A Virus
Severe Outcomes.
Epidemiologist....................... Novel Influenza A Virus 57 1 15/60
Case Screening Form.
Epidemiologist....................... Antiviral Resistant 57 3 30/60
Influenza Infection Case
Report Form.
Epidemiologist....................... National Respiratory & 550 52 15/60
Enteric Virus
Surveillance System
(NREVSS) (55.83A, B, D)
(electronic).
Epidemiologist....................... National Enterovirus 20 12 15/60
Surveillance Report:
(CDC 55.9) (electronic).
Epidemiologist....................... National Adenovirus Type 13 4 15/60
Reporting System (NATRS).
Epidemiologist....................... Middle East Respiratory 57 3 25/60
Syndrome (MERS) Patient
Under Investigation
(PUI) Short Form.
Epidemiologist....................... Viral Gastroenteritis 20 5 5/60
Outbreak Submission Form.
Epidemiologist....................... NORS Waterborne Disease 59 1 20/60
Transmission Form_52.12.
Epidemiologist....................... Influenza Virus 57 52 5/60
(Electronic, Year
Round), PHLIP_HL7
messaging Data Elements.
Epidemiologist....................... Influenza virus 3 52 5/60
(electronic, year round)
(PHIN-MS).
Epidemiologist....................... Suspect Respiratory Virus 10 5 30/60
Patient Form.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-18407 Filed 8-29-17; 8:45 am]
BILLING CODE 4163-18-P